Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Expects Pliant Partners: Deferring To Pfizer Skills And Strengths

Executive Summary

Pfizer expects its partners to defer to Pfizer in areas where it has a clear advantage in established skills and size, rather than push the joint arrangements as a way for the smaller firm to develop new functions

You may also be interested in...



Pfizer Partnership Philosophy Relies On One Manager, Five “C”s

Pfizer relies on one manager to oversee all aspects of an R&D agreement to help ensure that the goals identified in creating the partnership translate into day-to-day practice

Pfizer Partnership Philosophy Relies On One Manager, Five “C”s

Pfizer relies on one manager to oversee all aspects of an R&D agreement to help ensure that the goals identified in creating the partnership translate into day-to-day practice

NPS/Enzon Merger Provides Additional Leverage In Search For Preos Partner

The NPS/Enzon $1.6 bil. merger deal provides more leverage to the companies' search for a partner for the osteoporosis treatment Preos

Related Content

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel